Regeneron Pharmaceuticals Statistics

Total Valuation

BIT:1REGN has a market cap or net worth of EUR 63.62 billion. The enterprise value is 50.05 billion.

Market Cap	63.62B
Enterprise Value	50.05B

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Feb 19, 2026

Share Statistics

Current Share Class	99.92M
Shares Outstanding	n/a
Shares Change (YoY)	-5.65%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	3.83%
Owned by Institutions (%)	89.49%
Float	97.67M

Valuation Ratios

The trailing PE ratio is 16.58 and the forward PE ratio is 15.17.

PE Ratio	16.58
Forward PE	15.17
PS Ratio	5.21
PB Ratio	2.39
P/TBV Ratio	2.49
P/FCF Ratio	18.31
P/OCF Ratio	15.00
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.69, with an EV/FCF ratio of 14.40.

EV / Earnings	13.04
EV / Sales	4.09
EV / EBITDA	13.69
EV / EBIT	15.83
EV / FCF	14.40

Financial Position

The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.10.

Current Ratio	4.13
Quick Ratio	3.28
Debt / Equity	0.10
Debt / EBITDA	0.69
Debt / FCF	0.73
Interest Coverage	84.52

Financial Efficiency

Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 12.54%.

Return on Equity (ROE)	14.87%
Return on Assets (ROA)	5.91%
Return on Invested Capital (ROIC)	12.54%
Return on Capital Employed (ROCE)	10.23%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	792,722
Profits Per Employee	248,983
Employee Count	15,410
Asset Turnover	0.37
Inventory Turnover	2.53

Taxes

In the past 12 months, BIT:1REGN has paid 618.16 million in taxes.

Income Tax	618.16M
Effective Tax Rate	13.88%

Stock Price Statistics

The stock price has increased by +20.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+20.50%
50-Day Moving Average	652.80
200-Day Moving Average	583.04
Relative Strength Index (RSI)	47.64
Average Volume (20 Days)	1

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.13

Income Statement

In the last 12 months, BIT:1REGN had revenue of EUR 12.22 billion and earned 3.84 billion in profits. Earnings per share was 35.33.

Revenue	12.22B
Gross Profit	5.44B
Operating Income	3.15B
Pretax Income	4.45B
Net Income	3.84B
EBITDA	3.62B
EBIT	3.15B
Earnings Per Share (EPS)	35.33

Balance Sheet

The company has 7.33 billion in cash and 2.53 billion in debt, giving a net cash position of 13.54 billion.

Cash & Cash Equivalents	7.33B
Total Debt	2.53B
Net Cash	13.54B
Net Cash Per Share	n/a
Equity (Book Value)	26.62B
Book Value Per Share	259.47
Working Capital	11.63B

Cash Flow

In the last 12 months, operating cash flow was 4.24 billion and capital expenditures -765.17 million, giving a free cash flow of 3.48 billion.

Operating Cash Flow	4.24B
Capital Expenditures	-765.17M
Depreciation & Amortization	464.32M
Net Borrowing	n/a
Free Cash Flow	3.48B
FCF Per Share	n/a

Margins

Gross margin is 44.57%, with operating and profit margins of 25.81% and 31.41%.

Gross Margin	44.57%
Operating Margin	25.81%
Pretax Margin	36.47%
Profit Margin	31.41%
EBITDA Margin	29.60%
EBIT Margin	25.81%
FCF Margin	28.45%

Dividends & Yields

This stock pays an annual dividend of 3.10, which amounts to a dividend yield of 0.49%.

Dividend Per Share	3.10
Dividend Yield	0.49%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	8.22%
Buyback Yield	5.65%
Shareholder Yield	6.14%
Earnings Yield	6.03%
FCF Yield	5.46%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1REGN has an Altman Z-Score of 6.51 and a Piotroski F-Score of 4.

Altman Z-Score	6.51
Piotroski F-Score	4